Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall
Investing.com -- A panel of new vaccine advisers appointed by Health Secretary Robert F. Kennedy Jr. voted Friday to end the Centers for Disease Control and Prevention’s universal recommendation for Covid shots across all age groups.
The decision shifts Covid vaccination from a blanket recommendation to a personalized decision made between patients and their healthcare providers.
"We think it is appropriate to be discussed between a medical provider and a patient," said panelist Retsef Levi, a professor of operations management at the Massachusetts Institute of Technology who led the panel’s working group on Covid.
Levi stated that the group believes Covid booster effectiveness is based on "low-quality data and analyses" and cited unaddressed safety concerns as factors in their decision.
Covid vaccines have faced increased scrutiny since Kennedy, known for his vaccine-critical stance, was appointed as health secretary.
The CDC panel also voted against requiring prescriptions for Covid shots.
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) responded to the development by affirming their commitment to "making safe & effective vaccines."
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.